Heterogeneity in Excess Mortality Across Mental, Behavioural, and Neurodevelopmental Disorders

ImportanceExcess mortality associated with mental disorders is well established, but estimates are largely based on specialist psychiatric populations. Whether they characterize mortality in the broader diagnosed population is uncertain. ObjectiveTo characterize heterogeneity in excess mortality by diagnosis, psychiatric care setting, substance use disorder (SUD), and time since diagnosis. DesignNationwide population-based cohort study with follow-up from January 1, 2011, through December 31, 2023. SettingPrimary and specialist health care and population registers in Finland. ParticipantsResidents aged 5 to 95 years without a recorded prevalent mental disorder at cohort entry. ExposuresMental, behavioural, and neurodevelopmental disorders classified using ICD-11, with time-varying psychiatric care setting and SUD status. Main Outcomes and MeasuresAll-cause mortality, mortality rate ratios (MRRs), and 10-year differences in restricted mean survival time (RMST). Key PointsO_ST_ABSQuestionC_ST_ABSDoes excess mortality associated with mental disorders vary by diagnosis, clinical context, and time since diagnosis? FindingsIn this nationwide cohort study of 5.5 million individuals, excess mortality varied markedly by diagnosis, psychiatric care setting, comorbid substance use disorder, and time since diagnosis. For the 3 most common diagnostic groups, mortality approached that of individuals without the diagnosis during follow-up among those without substance use disorder treated outside specialist psychiatric care, whereas excess mortality persisted for psychotic disorders and higher-risk clinical subgroups. MeaningExcess mortality is not a uniform feature of mental disorder diagnosis; estimates derived from specialist psychiatric populations or averaged across follow-up may provide an incomplete picture of mortality in the broader diagnosed population. ResultsAmong 5,526,599 individuals (2,784,897 [50.4%] women), 1,463,064 (26.5%) received a mental disorder diagnosis. Excess mortality varied substantially by diagnosis, clinical subgroup, and time since diagnosis. Among those aged 5 to 64 years with any mental disorder, adjusted MRRs across care setting and SUD strata ranged from 1.54 (95% CI, 1.39-1.71) to 8.97 (7.86-10.24). MRRs were highest immediately after first diagnosis and declined during the first 2 to 3 years. At 3 years, MRRs for depressive, anxiety or fear-related, and stress-related disorders among individuals without SUD treated outside specialist psychiatric care ranged from 0.88 (0.79-0.98) to 1.20 (1.12-1.29) in men and from 0.81 (0.73-0.89) to 1.13 (1.04-1.22) in women, whereas MRRs for schizophrenia andother primary psychotic disorders remained 1.84 (1.60-2.12) in men and 1.55 (1.37-1.75) in women. Ten-year survival loss across all mental disorders was 0.53 years (95% CI, 0.53- 0.54) in men and 0.34 years (0.33-0.34) in women and was greater for natural than external causes. Conclusions and RelevanceExcess mortality varied markedly by diagnosis, clinical context, and time since diagnosis and was small in some common disorders outside specialist psychiatric care without SUD. Estimates derived from specialist psychiatric populations or averaged across follow-up may therefore provide an incomplete picture of mortality in the broader diagnosed population.